| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9193439 | Journal of Clinical Neuroscience | 2005 | 5 Pages |
Abstract
The quantification data clarified the behavior of Cho in malignant gliomas. The quantification method has the advantage of limiting the influence of other metabolites on Cho determination. In particular, the levels of other commonly measured metabolites, including Cre, may also be altered in glioma, making ratios between metabolites misleading. Heterogeneity in the MRS VOI should be considered when evaluating the proliferative activity of malignant glioma by MRS.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Akira MD PhD, Tomonori PhD, Izumi MD PhD, Shingo MD PhD, Hiraku BS,